Antibody Engineering
Therapeutics across miniprotein, fragment, and full-length formats
DiscoveryActive
Key Facts
Indication
Therapeutics across miniprotein, fragment, and full-length formats
Phase
Discovery
Status
Active
Company
About Lila Sciences
Lila Sciences is an ambitious AI-native biotech platform company founded in 2021, aiming to automate the entire scientific method. Its core offering, the 'AI Science Factory,' combines a proprietary AI model with autonomous laboratory hardware to accelerate R&D cycles from decades to months. While the company is private and likely pre-revenue, it has secured significant funding ($350M as of late 2025) and targets high-value discovery challenges across therapeutics, energy, materials, and more. Lila's success hinges on proving its platform's superiority over traditional research and other AI-driven approaches in generating validated, commercially viable discoveries.
View full company profile